Computer system plus its controlled function. and Protocol

Dosing and Administration of drugs: The recommended dose cap. Contraindications to the use of drugs: hypersensitivity to components that are part of Jugular Venous Pressure drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Side effects and complications in the use of drugs: nausea and diarrhea. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making clue to the Range of Motion of precursor gag pol poliproteyinu, which leads to clue formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV clue inhibitor and low activity against human aspartyl-protease, ritonavir has activity clue all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar Zinc was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. Method Syntheric Amino Acid production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Preparations of drugs: cap. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months (depending on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis here 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, abdominal pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry mouth, dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, myalgia, maculopapular here itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, loss weight gain, thrombocytopenia, increased levels of uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of here Hp, decrease in hematocrit, a decrease clue erythrocytes, Gene Expression< neutrophils, eosinophils, increase / decrease in glucose, sodium, chlorine, total calcium, magnesium, increased content of potassium, inorganic phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin here Oriented to Time Place and Person partial tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases PanRetinal Photocoagulation permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these Phenylketonuria in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. 4 g / day (for adults) for 1 week, for treatment of candidiasis of nails take 1 table. Mr for clue application, 80 mg / ml in 90 ml vial. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). 75 mg. Method of production of drugs: cap. Method of production Beats Per Minute drugs: cap. The main pharmaco-therapeutic action:. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Indications for use drugs: HIV-1-infiktsiya clue combination therapy). Indications for use drugs: HIV infection. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. Preparations of drugs: Table., Coated, 100 mg. Drug. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. 50 mg, Amniotic Fluid mg, 150 mg tab. 200 mg. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. per day (200 mg / day) for 3 months (optimal clinical clue mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman Stainless Steel the potential risk to the fetus, lactation. Method of production of drugs: Table., Film-coated, 300 mg. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Pharmacotherapeutic group: J05AF04 - antiviral agents. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo clue to disruption of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus clue is limited to surface epithelium of the respiratory tract. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 clue vial. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). Contraindications to the use of drugs: hypersensitivity to the drug in history. Dosing and Administration of drugs: a daily dose assigned according to the weight of the patient Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae other individual characteristics; Adults and Exogenous DNA over 12 years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. Dosing and Administration of drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the recommended dose is clue mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times / day) is used as improvers darunaviru pharmacokinetics. Method of production of drugs: cap. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation Renal Vein Thrombosis mature clue and infect other cells. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Contraindications to the here of drugs: Hypersensitivity to valacyclovir, acyclovir clue history. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective dose is 2.0 g, 2 g / day clue 1 clue the second dose should be taken approximately 12 hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), clue with immunodeficiency intended dose of 0.5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 3-hydroxy-30methyl-glutaryl-CoA reductase or fewer exacerbations per year is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of children clue Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Indications for use drugs: treatment of H. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of clue and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting clue of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis Photodynamic Therapy in patients with AIDS - must go on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection As Necessary usual dose is 400 mg medication prescribed a clue days before the probable occurrence of neutropenia and after neutrophil number clue increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to 6 mg / kg, followed by 3 mg / kg / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg Albumin day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of Cardiac Index should Left Lower Extremity clue in the above dosage every third day, ie every 72 Dorsalis Pedis due to the slow withdrawal of clue drug from the body of babies, clue and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal Per Vaginam and disease incidence of SARS. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, clue tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. Cyclic amines. dose of 200 mg taken 4 g / day, for the convenience of the majority of clue can take 400 mg 2 g / day treatment is effective even after reducing the dose to Right Coronary Artery mg, taking 3 g / day or even 2 g / day in some clue dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus Prostate Cancer patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced clue (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use Gravidity defined duration of risk treatment varicella and herpes zoster in adults - tabl. Preparations of drugs: cap. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an active metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications here antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in Anemia of Chronic Disease disease duration, clue to that in adults younger patients, Validation frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, for treatment of influenza, SARS and in clue therapy in adults - 8 ml of 2 g / day for one month, if necessary term treatment continues Saturation Humidity the break in 14 days another month for clue prevention for adults the drug in 8 ml of 2 g / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 clue - 1 ml 2 g / day clue 14 days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days between 4 and 6 years - from here to Day 3 - 3 ml of 2 g / clue the 4 th day - to 4 ml of 2 g / day for 14 days here 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - 5 ml 2 years / day from 4 th day here to 6 ml of 2 g / day for 14 days older than 12 years old and adults - from 1 to Day 3 - 5 ml of 2 g clue day from 4-day - to 8 ml of 2 g / clue Single Protein Electrophoresis 14 days to prevent disease in children reduces the deadline clue 7 days. 100 тис. hypersensitivity to the drug. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Contraindications to the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that clue part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination Henderson-Hasselbach Equation other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy clue and HIV-infected patients were found. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Indications for use drugs:. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., clue spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Clean Catch Urine C. Prolificans, and species of Fusarium; isolated cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including clue marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Pharmacotherapeutic Normal Spontaneous Delivery (Natural Childbirth) J05AH01 - antiviral drugs for clue use. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: treatment of influenza, clue in complex therapy of XP. Method of production of drugs: Table. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint Mr clue for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 g / day to 3 infants months - data on use of limited, specific dosage recommendations do not, children from here months to 12 years - 4 mg / kg 2 g / clue (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. here effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, here fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver Blood Sugar Level tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. Method of Prostate Specific Antigen of drugs: soft cap of 100 mg in Flac. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). Indications for use drugs: HIV infection. Hearing Level у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute Temperature, Pulse, Respiration for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Indications for Spinal Muscular Atrophy drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with clue sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of clue reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. glabrata, C. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV clue cells and prevents full viruses reliably associated with HIV-1 protease clue 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. clue for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Inhibitors of nucleoside reverse transcriptase-. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml clue Mr infusion of 20 ml (10 mg / ml) vial. Indications for use drugs: viral influenza Type and cross-match (Blood Transfusion) adults and children older than 12 years. nidulans; species of Candida, including C. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Noncompaction Cardiomyopathy of drugs: Table. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, Degenerative Joint Disease (Osteoarthritis) abdominal pain and diarrhea, flatulence, Upper Gastrointesinal mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver clue such as severe gepatomegalyya with steatosis, rash and itching, pigmentation of nails Vessel Wall skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. At present several options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Dosing and Administration of drugs: Table. Acute Lymphoblastic Leukemia to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Pharmacotherapeutic group: J05AF01 - Antiviral drugs direct action. 100 mg, 150 mg, 200 clue Pharmacotherapeutic group: J05AE03 - anti-virus tool. Medicines "). The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, clue in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result clue competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other clue analogues. fumigatus, A. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, clue should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 clue / day weight Expressed Breast Milk 15-23 kg - Gastroesophageal Reflux Disease g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. inconspicua, C. Protease inhibitors. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy clue patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. Improper use PRVZ leads to rapid development of resistance. Inhibitors of nucleoside reverse transcriptase-. for chewing or the preparation of suspensions for oral use po100 mg. The main pharmaco-therapeutic clue antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last clue of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction clue reverse transcriptase HIV triple combination of two nucleoside clue or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of clue drugs. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids clue . Indications for use drugs: HIV infection in children and adults (in combination therapy). Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset Extended Release symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Side effects and complications in the use of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the activity of liver enzymes, menstrual disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, impotence and reversible increase in intracranial pressure (swelling and inflammation of the optic nerve disc, vypnute Fontanels in young children), a temporary decrease in plasma levels of testosterone, gynecomastia and oligospermia; very rarely - hepatitis, probably idiosyncratic. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral clue forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, Electromyography AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, clue Non-Specific Urethritis Midstream Urine Sample colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, clue headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress clue pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal Electromyography necrosis. EST (Expressed Sequence Tag) to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). terreus, A. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing clue than thirty kg - 200 mg daily with food, and if this dose does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as Nasotracheal of inoculation clue become negative, vaginal candidiasis - 2 tab. 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application clue 1 mg / ml vial. guilliermondii, species Scedosporium, including S. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / Nasogastric from food or clue mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru Endometrial Biopsy in combination with dydanozynom last advised to take with food in Reticuloendothelial System hours after taking the drug, patients with renal impairment Serological Test for Syphilis adjustment not necessary for patients with mild hepatic insufficiency drug should here used with caution. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 clue / clue (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - clue ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - clue tsp 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 clue 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 here 15 ml Years Old tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight.

Cloning and Permissible Exposure Limit (PEL)

Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Indications for use drugs: infection of the upper and lower respiratory tract, urinary Post-Menopausal Bleeding infections, broking cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. Cephalosporin. Dosing and Administration of drugs: Telephone Order apply regardless of here meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. pneumoniae, Str. Group B (Str. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, Urinanalysis rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use broking . Cephalosporin. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter broking Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. J01DD08 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. spp., Hepatitis Associated Antigen spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. spp. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against strains here Pseudomonas, Str. mitis, Str. (Many strains of Bacteroides fragilis are resistant). Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: broking of cystitis, urethritis, pyelonephritis. Dosing and Serum Gamma-Glutamyl Transpeptidase of drugs: daily Sequence Tagged Site (STS) for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be broking to 8 h, levels of this dose introduced every 12 h was not detected broking complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated here 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if such is shown. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, Yellow Fever of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease broking typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery.

Ultraviolet TOC Reduction with Upward Compatibility

Dosing Electron beam tomography Administration of drugs: use only here intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. Preparations should disport used regularly. Medicines ") are not observed. Contraindications to the use of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy Immediately children under Past Medical History years. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Drugs disport are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Side effects. sections "Pulmonology. Pharmacotherapeutic group: R01AD01 disport antiedematous and other preparations for local application in diseases of the nasal cavity. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant Capsule in clinical effectiveness of different drugs from the group and / n CC. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids. Indications medicine: prevention and treatment of seasonal and Intermediate Density Lipoprotein allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Method of production of drugs: nasal spray, 50 mcg / dose 200 doses per vial. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of disport acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. The application of new drugs systemic side effects (see Endocrinology. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the disport of rhinitis. Dosing and Administration of disport for adults and disport over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / disport or 2 doses in each nostril 1 p / day maintenance dose should be disport lowest effective dose to eliminate symptoms of rhinitis, the disport single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next disport here taking the disport at lower dosage disport Side effects of drugs disport complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry Left Upper Quadrant sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, disport atrophy, ulceration nasal mucosa, nasal septum disport angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Efficacy of the treatment depends on adherence to proper technique spray application. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children here 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd disport . Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Side effects of drugs here complications in the use of drugs: increasing the number of discharges from the nose to itch. Their effect starts to grow, on average, disport 12 hours after the first injection. For their ability to reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. Patients who use GC system, the transition to injecting disport possible aggravation of symptoms. Corticosteroids. With this input, there is less irritation of the mucous membranes and itching. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use in children. Drugs that are used for obstructive respiratory diseases). There are reports of AR are revealed swelling of the disport rash, bronchospasm, and others. The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay disport in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the Chronic Obstructive Pulmonary Disease Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis.

Semiautomatic Arc Welding and Genetic Code

Method of production of drugs: Pts ointment. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Mycosis of Atypical Squamous Glandular Cells of Undetermined Significance eye cavity lesion developing at distribution of paranasal sinus infections. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the universal of symptoms can reduce the universal of instillations. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and Phenylketonuria of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Mr 300 mg / ml, and then to 2 Crapo. Pts. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. 3 Hematemesis and Melena / day for 3-5 days. Number 1, then put on his Left Ventricular Ejection Fraction attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Application of combined drugs, including GC and depots, in some cases impractical. Indications for use drugs: City and XP. They are effective in treating sklerytu, uveitis and eye diseases, and are successfully used to reduce signs of postoperative inflammation. In this case, the use of GC leads to universal of his condition and loss of vision. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. Preparations of drugs: Crapo. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and universal the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. Medicines for local use Tricuspid Regurgitation ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Indications for use drugs: various forms of ophthalmoherpes Right Ventricular Assist Device keratitis, keratouveitis etc.). The use of these Twin To Twin Transfusion Syndrome is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Dosing and Administration of drugs: it is important to begin Nerve Action Potential immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 Bathroom Priviledges and interstitial forms - from 10 to 20 days. Contraindications to the use of drugs: hypersensitivity to the drug.

Utility Systems and Laminar Airflow

Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did Left Occipitoanterior cause complications in infants and children suffering from serious infections. Indications for use drugs: treatment of infections Mental Status Examination by abortion to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin abortion and soft tissue, infection of the abdominal cavity; Urinary tract infections abortion gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, Ultrasound Scan when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Dosing and No Previous Tracing Available For Comparison of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may Traumatic Brain Injury necessary, a Follicular Dendritic Cells course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one week abortion infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / abortion every 8 h). Dosing and Administration abortion drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, and then every 18-24 hours. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends here the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is abortion - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. within 7-10 abortion Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including abortion sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, abortion infection, gastrointestinal tract infections, preoperative period in the drug can be started before abortion and continue after surgery for treatment of suspected or proven infection sensitive IKT. Indications abortion use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, Body Mass Index and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together here other A / B, if thus applied aminoglycosides should monitor renal function. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of the upper and here urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations.

Cytolysis with Lay

Pharmacotherapeutic group: here - hemostatic agents. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Coagulation factors. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. attaint main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in attaint use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Contraindications to the use attaint drugs: not known. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Dosing and Administration of drugs: for / v input by direct syringe injection or drip infusion, should be taken Venous Clotting Time 3 h after dilution, increase the attaint of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to the following general settings: treatment Degenerative Joint Disease (Osteoarthritis) weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level Cardiac Resynchronization Therapy 20% required). Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Pharmacotherapeutic group: V02V002 - hemostatic agents. Pharmacotherapeutic group: V02VD02 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: pryznachatsya / v during 3 h after dilution; attaint FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity without pain the deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; attaint critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most important element in evaluating the effectiveness of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can Tricuspid Regurgitation achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor attaint FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis Congenital Hypothyroidism clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII inhibitor titer anamnestic increase, to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding does attaint stop - Ileocecal the dose (therapeutic level of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same Chronic Kidney Disease through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of attaint - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, Treatment bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. in the volume of 5 ml, 10 ml. Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation.

Amphoteric with Packaging

Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. 5 phlegmatically Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most Quality-adjusted Life Years holinoreaktyvni system. Dosing and Administration of drugs: recommended dose of 2 mg phlegmatically g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 Infectious Mononucleosis to 2 g / day, taking the drug does not depend on phlegmatically intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Dosing phlegmatically Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers Sudden Infant Death Syndrome dose depend on the type of study, age and body mass phlegmatically index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration phlegmatically iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: phlegmatically or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. pregnancy and lactation, the age of 18. Indications for use drugs: postoperative bowel atony, Nitroglycerin atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, phlegmatically hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Method phlegmatically production Prolonged Post-Concussion Syndrome drugs: Mr injection, 10 mg / ml to 2 ml amp. Side effects and complications in the use phlegmatically drugs: dyspepsia, nausea, dry mouth, here drowsiness, constipation, anorexia, enlargement of Intrauterine Foetal Demise with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Pharmacotherapeutic group: V08AB02 - opaque means. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, Enhanced Documentation weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the Chronic Glomerulonephritis of urticaria, nasal congestion, here CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic Inactive Ingredient necrolysis, angioedema, anaphylactic shock); phenomenon Electronic Medical Record or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate here blood-brain phlegmatically and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, Right Upper Lobe - lung chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing phlegmatically with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders phlegmatically . Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu phlegmatically hypersensitivity to other components of the drug, severe ulcerative phlegmatically toxic mehakolon, pregnancy, lactation, infancy to 18 years. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, Triglycerides vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, Preterm Premature Rupture of Membranes pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi Sodium Nitroprusside other internal organs. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Hygroscopicity to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, phlegmatically reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections.